Adaptive Biotechnologies
ADPT · US
Adaptive Biotechnologies is held by 3 of the 24 tracked investors in their latest 13F filings. The largest position is Viking Global Investors's at $643M, 1.83% of that portfolio. Versus the prior quarter, 0 added, 1 trimmed and 0 bought new.
Big investors holding this stock
Latest 13F of the 24 tracked investors. Common shares only.
| Investor | Value ($) | vs prior quarter |
|---|---|---|
| Viking Global Investors weight 1.83% · Q2 2026 |
643M | – |
| ARK Investment Management weight 0.29% · Q2 2026 |
44.8M | – |
| Bridgewater Associates weight 0.00% · Q2 2026 |
0.9M | ▼ 55% |
Questions
Which big investors own Adaptive Biotechnologies?
Viking Global Investors ($643M), ARK Investment Management ($44.8M), Bridgewater Associates ($859,866), per their latest 13F filings.
Does Warren Buffett own Adaptive Biotechnologies?
Berkshire Hathaway did not report it in its latest 13F.
Does Korea's National Pension Service own Adaptive Biotechnologies?
Not in its latest 13F.
Restated and computed from SEC (13F, 13D/G, Form 4) and DART filings and NPS public data. Filings describe a past date and may differ from current holdings (13F: quarter end, up to 45 days later). Not investment advice.
Sources: SEC EDGAR, DART, data.go.kr (NPS), OpenFIGI. See Methodology for how figures are computed.